// App-Quantinova.ai

OC 57.3 : Cell-based high throughput screening to identify FDA/EMA approved drugs that inhibit the endothelial pro-thrombotic switch during severe COVID19 infection

Researchers

Presenter

  • D. Jones

Principal Investigators

  • E. Schneider

  • M. Appiah

  • G. Birdsey

  • T. McKinnon

  • R. Thwaites

Medical Centers

  • NCRI and Imperial College London, London, United Kingdom

  • Imperial College London, london, England, United Kingdom

  • University of Bordeaux, Bordeaux, Aquitaine, France

  • University of Trieste, Trieste, Friuli-Venezia Giulia, Italy

  • SGDP, IoP, King's College London, London, England, United Kingdom

Locations

  • United Kingdom

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cancer antigen 15-3

  • Intercellular adhesion molecule 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved